These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24059412)

  • 1. Anaphylactic shock due to vitamin K in a newborn and review of literature.
    Koklu E; Taskale T; Koklu S; Ariguloglu EA
    J Matern Fetal Neonatal Med; 2014 Jul; 27(11):1180-1. PubMed ID: 24059412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylactic reactions with intravenous vitamin K: lessons from the bedside.
    Jethava A; Mathew J; Dasanu CA
    Conn Med; 2012 Oct; 76(9):549-50. PubMed ID: 23155674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole administration leading to anaphylactic shock in a preterm newborn.
    Koklu E; Kalay S; Koklu S; Ariguloglu EA
    Neonatal Netw; 2014; 33(2):83-5. PubMed ID: 24589899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemorrhagic disease of the newborn and vitamin K prophylaxis.
    Gnegy R
    W V Med J; 1973 Oct; 69(10):278-9. PubMed ID: 4584461
    [No Abstract]   [Full Text] [Related]  

  • 5. Twenty-seven years of experience with oral vitamin K1 therapy in neonates.
    Clark FI; James EJ
    J Pediatr; 1995 Aug; 127(2):301-4. PubMed ID: 7636660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of childhood cancer after neonatal exposure to vitamin K.
    Klebanoff MA; Read JS; Mills JL; Shiono PH
    N Engl J Med; 1993 Sep; 329(13):905-8. PubMed ID: 8361503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternally administered antenatal vitamin K1: effect on neonatal prothrombin activity, partial thromboplastin time, and intraventricular hemorrhage.
    Pomerance JJ; Teal JG; Gogolok JF; Brown S; Stewart ME
    Obstet Gynecol; 1987 Aug; 70(2):235-41. PubMed ID: 3601288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of oral and intramuscular vitamin K on the factors II, VII, IX, X, and PIVKA II in the infant newborn under 60 days of age].
    Arteaga-Vizcaíno M; Espinoza Holguín M; Torres Guerra E; Diez-Ewald M; Quintero J; Vizcaíno G; Estévez J; Fernández N
    Rev Med Chil; 2001 Oct; 129(10):1121-9. PubMed ID: 11775338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal administration of vitamin K does not improve the coagulation profile of preterm infants.
    Kazzi NJ; Ilagan NB; Liang KC; Kazzi GM; Poland RL; Grietsell LA; Fujii Y; Brans YW
    Pediatrics; 1989 Dec; 84(6):1045-50. PubMed ID: 2587133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avoidable hazard to New Zealand children: case reports of haemorrhagic disease of the newborn.
    Heron P; Cull A; Bourchier D; Lees H
    N Z Med J; 1988 Aug; 101(851):507-8. PubMed ID: 3405530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Administration of vitamin K to neonates and infants].
    Uitentuis J
    Ned Tijdschr Geneeskd; 1990 Aug; 134(34):1642-6. PubMed ID: 2215706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of vitamin K to newborn infants and childhood cancer.
    Ekelund H; Finnström O; Gunnarskog J; Källén B; Larsson Y
    BMJ; 1993 Jul; 307(6896):89-91. PubMed ID: 8343734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies surrounding the administration of vitamin K to newborns: a review.
    Brousson MA; Klein MC
    CMAJ; 1996 Feb; 154(3):307-15. PubMed ID: 8564900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should intramuscular vitamin K prophylaxis for haemorrhagic disease of the newborn be continued? A decision analysis.
    Brown SG; McHugh G; Shapleski J; Wotherspoon PA; Taylor BJ; Gillett WR
    N Z Med J; 1989 Jan; 102(860):3-5. PubMed ID: 2643775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral vitamin K1: the effective prophylaxis against haemorrhagic disease for all newborn infants.
    Clarkson PM; James AG
    N Z Med J; 1990 Mar; 103(885):95-6. PubMed ID: 2179775
    [No Abstract]   [Full Text] [Related]  

  • 16. Anaphylactoid reactions to vitamin K.
    Fiore LD; Scola MA; Cantillon CE; Brophy MT
    J Thromb Thrombolysis; 2001 Apr; 11(2):175-83. PubMed ID: 11406734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal antenatal administration of vitamin K1 results in increasing the activities of vitamin K-dependent coagulation factors in umbilical blood and in decreasing the incidence rate of periventricular-intraventricular hemorrhage in premature infants.
    Liu J; Wang Q; Gao F; He JW; Zhao JH
    J Perinat Med; 2006; 34(2):173-6. PubMed ID: 16519625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation.
    Liu J; Wang Q; Zhao JH; Chen YH; Qin GL
    J Trop Pediatr; 2006 Oct; 52(5):355-9. PubMed ID: 16751657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversies concerning vitamin K and the newborn. American Academy of Pediatrics Committee on Fetus and Newborn.
    American Academy of Pediatrics Committee on Fetus and Newborn
    Pediatrics; 2003 Jul; 112(1 Pt 1):191-2. PubMed ID: 12837888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K prophylaxis in the newborn.
    Darlow B
    N Z Med J; 1993 Feb; 106(950):67-8. PubMed ID: 8437772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.